Duke alumnus and Rhodes Scholar Ariel Kantor was selected for Forbes Europe's latest "30 under 30" — an annual listing of top young innovators, entrepreneurs and world changers.
As part of the Science and Healthcare category, Kantor was recognized for his important contributions to the field of gene editing, including co-founding two new companies in the field.
He is currently vice president of business development and platform strategy at California-headquartered ReCode Therapeutics and
September 11, 2024
September 11, 2024
September 9, 2024